Effects of the Upregulated Twist Gene Expression on the Proliferation, Apoptosis, and Invasive Capability of Human Colon Cancer SW480 cells
-
摘要:
目的 上调人结肠癌SW480细胞株中Twist基因的表达,观察其对细胞增殖、凋亡及侵袭能力的影响。 方法 将高表达Twist基因的质粒和空载质粒稳定转染SW480细胞,分别命名为转染组和对照组,MTT法、细胞划痕实验和Matrigel侵袭实验分别检测肿瘤细胞体外增殖、迁移及侵袭能力的变化。FCM检测细胞周期及凋亡情况。将肿瘤细胞接种至裸鼠皮下,对比转染前后肿瘤细胞的成瘤情况。 结果 从第4天开始,转染组SW480细胞生长速度明显高于对照组(P < 0.05);转染组SW480细胞的增殖指数(PI)和S期细胞比例[(61.279±1.709)%,(33.171±3.154)%]均高于对照组[(26.142±1.518)%,(14.112±2.137)%](P < 0.05);转染组的细胞凋亡率(6.831±1.624)%低于对照组(12.223±1.733)%(P < 0.05);划痕24 h及48 h时后转染组细胞迁移率[(40.06± 5.56)%,(75.77±8.06)%]均高于对照组[(25.25±2.65)%,(35.37±6.79)%](P < 0.05);Matrigel侵袭实验结果显示转染组侵袭细胞个数明显高于对照组(P < 0.05);将两组细胞分别接种裸鼠,16 d左右可见肿瘤结节,转染组肿瘤体积及瘤重均大于对照组(P < 0.05)。 结论 上调Twist基因可提高SW480细胞体外增殖、迁移和侵袭能力,降低SW480细胞凋亡率。 Abstract:Objective To evaluate the effects of the Twist gene on cell proliferation, apoptosis, and invasive capability of colon cancer SW480 cells. Methods SE480 cells were transfected with highly expressed Twist plasmid. MTT was used to monitor cell proliferation, wound-healing assay to observe cell motility rate, Matrigel invasion assay to observe cell invasiveness, and flow cytometry (FCM) to observe the effect of the Twist gene on the cell cycle and apoptosis. The cells were injected into nude mice, and the tumor forming condition was observed. Results The growth rate of the stably transfected group was significantly higher than that in the control group since day 4 (P < 0.05). The proliferation index (PI) of the transfected group was 61.279% ± 1.709%, and the percentage of cells in S stage was 33.171% ± 3.154%, significantly higher than those in the control group (26.142% ± 1.518%, 14.112% ± 2.137%, P < 0.05). Cells in the transfected group rapidly migrated and closed the wound by 40.06% ± 5.56% and 75.77% ± 8.06% at 24 and 48 h, respectively, significantly higher than the control group (25.24% ± 2.65%, 35.37%±6.79%). The apoptosis rate of the SW480 cells in the transfected group (6.831% ± 1.624%) was significantly lower than that of the control group (12.223% ± 1.733%) (P < 0.05). The tumor was observed at 16 days after injecting the transfected cells into nude mice. The tumor volume in the transfected group was significantly larger than that in the corrtrol cells control group (P < 0.05). The tumor was significantly heavier in the transfected group than that in the control group (P < 0.05). Conclusion The upregulated expression of Twist gene can increase the proliferation, migration, and invasion capability of SW480 cells and lower the apoptosis rate of the SW480 cells. -
Key words:
- Colon cancer cell /
- Twist gene /
- Proliferation /
- Invasion /
- Apoptosis
-
表 1 转染后Twist mRNA及蛋白在SW480细胞中的表达
(x±s) Table 1. The expression of Twist mRNA and protein in SW480 cells after transfection
(x±s) 表 2 转染后Twist对细胞增殖的影响
x±s Table 2. The effect of Twist on cell growth after transfection
(x±s) 表 3 转染后Twist对SW480细胞迁移及侵袭能力的影响
Table 3. The effect of Twist on cell migration and motility after transfection in SW480 cells
(x±s) 表 4 转染Twist基因后对SW480细胞凋亡及细胞周期的影响
Table 4. The effect of Twist on cell apoptosis and cell cycle after transfection in SW480 cells
(x±s) 表 5 Twist对裸鼠移植瘤体积增长的影响
Table 5. The effect of Twist on the growth of implanted tumor in nude mice
(x±s) -
[1] Winawer SJ. A quarter century of colorectal cancer screening: progress and prospects[J]. J Clin Oncol, 2001, 19(18 Suppl): 6S-12S. http://www.ncbi.nlm.nih.gov/pubmed/11560964 [2] Evan G, Littlewood T. A matter of life and cell death[J]. Scinece, 1998, 281(5381): 1317-1321. doi: 10.1126/science.281.5381.1317 [3] Kang Y, Massague J. Epithelial mesenchymal transitions: twist in development and metastasis[J]. Cell, 2004, 118(3): 277-279. doi: 10.1016/j.cell.2004.07.011 [4] Baumgart E, Cohen MS, Silva Neto B, et al. Identification and prognosis significance of an epithelial-mesenchymal transition expression profile in human bladder tumors[J]. Clin J Cancer Res, 2007, 13 (6): 1685-1694. doi: 10.1158/1078-0432.CCR-06-2330 [5] Rosivatz E, Becker I, Specht K, et al. Differential Expression of the epithelial-mesenchymal transition regulators snail, Sip1, and Twist in gastric cancer[J]. Am J Pathol, 2002, 161(5): 1881-1891. doi: 10.1016/S0002-9440(10)64464-1 [6] Horikawa T, Yang J, Kondo S, et al. Twist and epithelial-mesenchymal transition are induced by the EBV oncoporotein latentmembrane protein 1 and are associated with metastatic nasopharyngeal carcinoma[J]. Cancer Res, 2007, 67(5): 1970-1978. doi: 10.1158/0008-5472.CAN-06-3933 [7] Funato N, Twigg SR, Higashihori N, et al. Functional analysis of natural mutations in two twist protein motifs[J]. Human Mutat, 2005, 25(6): 550 -556. doi: 10.1002/humu.20176 [8] Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis[J]. Cell, 2004, 117(7): 927-939. doi: 10.1016/j.cell.2004.06.006 [9] Lo HW, Hsu SC, Xia W, et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression[J]. Cancer Res, 2007, 67(19): 9066-9076. doi: 10.1158/0008-5472.CAN-07-0575 [10] Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition[J]. Clin Cancer Res, 2006, 12(18): 5369-5376. doi: 10.1158/1078-0432.CCR-05-2722 [11] Mironchik Y, Winnard PT Jr, Vesuna F, et al. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer[J]. Cancer Res, 2005, 65(23): 10801-10809. doi: 10.1158/0008-5472.CAN-05-0712 [12] Stasiopoulos IA, Mironchik Y, Raman A, et al. HOXA5 twist interaction alters p53 homeostasis in breast cancer cells[J]. J Biol Chem, 2005, 280(3): 2294-2299. doi: 10.1074/jbc.M411018200 [13] Hamamori Y, Sartorelli V, Ogrysko V, et al. Regulation of histone acetyl transferases p300 and PCAF by the Bhlh protein twist and adenoviral oncoprotein E1A[J]. Cell, 1999, 96(3): 405-413. doi: 10.1016/S0092-8674(00)80553-X [14] Saporita AJ, Maggi LB, Apicelli AJ, et al. Therapeutic targets in the ARF tumor suppressor pathway[J]. Curr Med Chem, 2007, 14(17): 1815-1827. doi: 10.2174/092986707781058869 [15] Wang X, Ling MT, Guan XY, et al. Identification of a novel function of Twist, a bHLH protein, in the development of acquired taxol resistance in human cancer cells[J]. Oncogene, 2004, 23(2): 474-482. doi: 10.1038/sj.onc.1207128 [16] 刘晓燕, 王丽, 何涛, 等. Twist在几种不同肿瘤细胞系中的差异表达[J]. 泸州医学院院报, 2010, 33(2): 128-130. https://www.cnki.com.cn/Article/CJFDTOTAL-LXYB201002008.htm [17] Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target[J]. Cancer Res, 2005, 65(12): 5153-5162. doi: 10.1158/0008-5472.CAN-04-3785